Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Alternative Energy ‘Green’ hydrogen can reduce global carbon emissions: IMTY 'It Matters To You' discusses the potential impact of the alternative energy source down under and around the globe Rowan DunneOctober 28, 2022
Sleep Cymbiotika unveils new herbal ‘Sleep’ product The new product will cost US$38 per bottle and for those in Canada there is currently a wait list for it Rowan DunneOctober 28, 2022
Canada Spirit Plant Medicine Conference returns at UBC to discuss psychedelics and consciousness 11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from Florida Rowan DunneOctober 28, 2022
Cannabis Germany unveils plan to legalize adult-use cannabis The nation is set to be the second in Europe to permit the use of recreational pot Rowan DunneOctober 27, 2022
Technology Internet and media businesses will gain US$400B by 2026: Activate Consulting The hype over NFT's has also come to an end, according to the management consulting firm Rowan DunneOctober 26, 2022
Canada New ‘CB2’ oil is superior to CBD: Cannanda Company claims the extract has better bioavailability, a higher success rate and is perfectly legal to travel with internationally Rowan DunneOctober 26, 2022
Cannabis American SEC charges Cronos Group for financial fraud Cronos was charged with accounting misconduct in several reporting periods and improper bookkeeping for millions in revenue Rowan DunneOctober 25, 2022
Cannabis Impending legalization offers investment opportunities in the U.S. cannabis market: KEY Investment Partners 'Cannabis 2.0: Investing in Today's Regulated Industry' is said to provide insight into financial opportunities and modern trends Rowan DunneOctober 24, 2022
Psychedelics Algernon partners with Yale University for phase II DMT study Algernon will provide cGMP DMT for the study in exchange for part-ownership of IP generated Rowan DunneOctober 24, 2022